Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
Jeong Pil Han, M. Kim, Beom Seok Choi, et al.
Science Advances (2022) Vol. 8, Iss. 3
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery
Xu Wang, Shuai Liu, Yehui Sun, et al.
Nature Protocols (2022) Vol. 18, Iss. 1, pp. 265-291
Open Access | Times Cited: 254
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Michaela Jeong, Yeji Lee, Jeongeun Park, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114990-114990
Closed Access | Times Cited: 97
mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 79
Chemically Modified Platforms for Better RNA Therapeutics
Yesi Shi, Xueyan Zhen, Yiming Zhang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 929-1033
Closed Access | Times Cited: 52
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
Frazer Sinclair, Anjuman Ara Begum, Charles C. Dai, et al.
Drug Delivery and Translational Research (2023) Vol. 13, Iss. 5, pp. 1500-1519
Open Access | Times Cited: 46
Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets
Maryam Taghdiri, Claudio Mussolino
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7333-7333
Open Access | Times Cited: 27
mRNA therapies: Pioneering a new era in rare genetic disease treatment
Guobo Shen, Jian Liu, Hanmei Yang, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 696-721
Closed Access | Times Cited: 20
2025 Clinical Trials Update on Hemophilia, VWD, and Rare Inherited Bleeding Disorders
Debbie Jiang, Michael Wang, Allison P. Wheeler, et al.
American Journal of Hematology (2025)
Closed Access | Times Cited: 3
Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing
Elizabeth Maria Clarissa, Mamata Karmacharya, Hyun‐Min Choi, et al.
Small (2025)
Closed Access | Times Cited: 2
Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs
Yamin Li, Zhongfeng Ye, Hanyi Yang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 6, pp. 2624-2639
Open Access | Times Cited: 60
Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery
Xiao Xu, Tian Xia
ACS Nanoscience Au (2023) Vol. 3, Iss. 3, pp. 192-203
Open Access | Times Cited: 38
CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
Deepak Kumar Sahel, Lalitkumar K. Vora, Aishwarya Saraswat, et al.
Advanced Science (2023) Vol. 10, Iss. 19
Open Access | Times Cited: 36
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
Hao Yang, Zhong‐Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 34
Ionizable Lipid Nanoparticles for mRNA Delivery
Xuefeng Tang, Ying Zhang, Xiaojun Han
Advanced NanoBiomed Research (2023) Vol. 3, Iss. 8
Open Access | Times Cited: 31
Microfluidic Devices for Precision Nanoparticle Production
Ayşenur Bezelya, Berrin Küçüktürkmen, Asuman Bozkır
Micro (2023) Vol. 3, Iss. 4, pp. 822-866
Open Access | Times Cited: 28
Use of Microfluidics to Prepare Lipid-Based Nanocarriers
Alicia Vogelaar, Samantha Marcotte, Jiaqi Cheng, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1053-1053
Open Access | Times Cited: 27
The mixing method used to formulate lipid nanoparticles affects mRNA delivery efficacy and organ tropism
Daria M. Strelkova Petersen, Namit Chaudhary, Mariah L. Arral, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 192, pp. 126-135
Open Access | Times Cited: 26
High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
Hanjin Seo, Leekang Jeon, Jaeyeong Kwon, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 13
Closed Access | Times Cited: 25
Recent Advances in Genome-Engineering Strategies
Michaela A. Boti, Konstantina Athanasopoulou, Panagiotis G. Adamopoulos, et al.
Genes (2023) Vol. 14, Iss. 1, pp. 129-129
Open Access | Times Cited: 24
Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies
Pu-Sheng Wei, Nagasri Thota, Gresham John, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 366-388
Open Access | Times Cited: 17
Development of mRNA Lipid Nanoparticles: Targeting and Therapeutic Aspects
Yaping Liu, Yingying Huang, Guantao He, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10166-10166
Open Access | Times Cited: 16
Recent Therapeutic Gene Editing Applications to Genetic Disorders
Éric Deneault
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4147-4185
Open Access | Times Cited: 12
Lipid Nanocarrier‐Based mRNA Therapy: Challenges and Promise for Clinical Transformation
Wenchao Li, Chen Wang, Yifei Zhang, et al.
Small (2024) Vol. 20, Iss. 28
Closed Access | Times Cited: 10
Kinetics of RNA-LNP delivery and protein expression
Judith Müller, Nathalie Gabriele Schäffler, Thomas Kellerer, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 197, pp. 114222-114222
Open Access | Times Cited: 10
Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Shruti Patil, Balasankara Reddy Kaipa, Sujata Ranshing, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top